Israel’s Votis Subdermal Imaging Technologies develops devices to diagnose Peripheral Artery Disease (PAD) affecting 200+ million people globally. The condition affects mainly diabetics and can lead to Chronic limb-threatening ischemia (CLTI) with the subsequent need to amputate the feet.